BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feldman MF, Mayer Bridwell AE, Scott NE, Vinogradov E, McKee SR, Chavez SM, Twentyman J, Stallings CL, Rosen DA, Harding CM. A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae. Proc Natl Acad Sci U S A 2019;116:18655-63. [PMID: 31455739 DOI: 10.1073/pnas.1907833116] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Chiarelli A, Cabanel N, Rosinski-Chupin I, Zongo PD, Naas T, Bonnin RA, Glaser P. Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae. BMC Microbiol 2020;20:325. [PMID: 33109078 DOI: 10.1186/s12866-020-02007-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dow JM, Mauri M, Scott TA, Wren BW. Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production. Expert Review of Vaccines 2020;19:507-27. [DOI: 10.1080/14760584.2020.1775077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Twentyman J, Morffy Smith C, Nims JS, Dahler AA, Rosen DA. A murine model demonstrates capsule-independent adaptive immune protection in survivors of Klebsiella pneumoniae respiratory tract infection. Dis Model Mech 2020;13:dmm043240. [PMID: 32298236 DOI: 10.1242/dmm.043240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Peng Z, Wu J, Wang K, Li X, Sun P, Zhang L, Huang J, Liu Y, Hua X, Yu Y, Pan C, Wang H, Zhu L. Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host. Adv Sci (Weinh) 2021;8:e2100549. [PMID: 34032027 DOI: 10.1002/advs.202100549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jiang X, Bai J, Zhang H, Yuan J, Lu G, Wang Y, Jiang L, Liu B, Huang D, Feng L. Development of an O-polysaccharide based recombinant glycoconjugate vaccine in engineered E. coli against ExPEC O1. Carbohydr Polym 2022;277:118796. [PMID: 34893224 DOI: 10.1016/j.carbpol.2021.118796] [Reference Citation Analysis]
6 Li X, Pan C, Liu Z, Sun P, Hua X, Feng E, Yu Y, Wu J, Zhu L, Wang H. Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice. Microb Biotechnol 2021. [PMID: 33755314 DOI: 10.1111/1751-7915.13770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Tummillo KM, Hazlett KRO. Co-Opting Host Receptors for Targeted Delivery of Bioconjugates-From Drugs to Bugs. Molecules 2021;26:1479. [PMID: 33803208 DOI: 10.3390/molecules26051479] [Reference Citation Analysis]
8 Nothaft H, Perez-Muñoz ME, Yang T, Murugan AVM, Miller M, Kolarich D, Plastow GS, Walter J, Szymanski CM. Improving Chicken Responses to Glycoconjugate Vaccination Against Campylobacter jejuni. Front Microbiol 2021;12:734526. [PMID: 34867850 DOI: 10.3389/fmicb.2021.734526] [Reference Citation Analysis]
9 Lee S, Inzerillo S, Lee GY, Bosire EM, Mahato SK, Song J. Glycan-mediated molecular interactions in bacterial pathogenesis. Trends Microbiol 2021:S0966-842X(21)00143-8. [PMID: 34274195 DOI: 10.1016/j.tim.2021.06.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Buchy P, Ascioglu S, Buisson Y, Datta S, Nissen M, Tambyah PA, Vong S. Impact of vaccines on antimicrobial resistance. Int J Infect Dis 2020;90:188-96. [PMID: 31622674 DOI: 10.1016/j.ijid.2019.10.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
11 Liu D, Chen Z, Yuan Y, Jing H, Zou J, Zhang X, Zeng X, Zhang W, Zou Q, Zhang J. Innate Immune Effectors Play Essential Roles in Acute Respiratory Infection Caused by Klebsiella pneumoniae. J Immunol Res 2020;2020:5291714. [PMID: 33163539 DOI: 10.1155/2020/5291714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Assefa M. Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns. Pneumonia (Nathan) 2022;14:4. [PMID: 35509063 DOI: 10.1186/s41479-022-00096-z] [Reference Citation Analysis]
13 Lan P, Jiang Y, Zhou J, Yu Y. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist 2021;25:26-34. [PMID: 33667703 DOI: 10.1016/j.jgar.2021.02.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Micoli F, Bagnoli F, Rappuoli R, Serruto D. The role of vaccines in combatting antimicrobial resistance. Nat Rev Microbiol 2021;19:287-302. [PMID: 33542518 DOI: 10.1038/s41579-020-00506-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
15 Arato V, Raso MM, Gasperini G, Berlanda Scorza F, Micoli F. Prophylaxis and Treatment against Klebsiella pneumoniae: Current Insights on This Emerging Anti-Microbial Resistant Global Threat. Int J Mol Sci 2021;22:4042. [PMID: 33919847 DOI: 10.3390/ijms22084042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Cross AS, Opal SM, Palardy JE, Shridhar S, Baliban SM, Scott AJ, Chahin AB, Ernst RK. A pilot study of an anti-endotoxin Ig-enriched bovine colostrum to prevent experimental sepsis. Innate Immun 2021;27:266-74. [PMID: 33858243 DOI: 10.1177/17534259211007538] [Reference Citation Analysis]
17 Zou J, Chen Z, Zhang X, Yuan Y, Jing H, Zou Q, Zhang J. Genome Sequence of Klebsiella pneumoniae YBQ, a Clinical Strain Isolated from the Sputum of a Patient with Severe Pneumonia. Microbiol Resour Announc 2020;9:e01223-20. [PMID: 33214313 DOI: 10.1128/MRA.01223-20] [Reference Citation Analysis]
18 Kightlinger W, Warfel KF, DeLisa MP, Jewett MC. Synthetic Glycobiology: Parts, Systems, and Applications. ACS Synth Biol 2020;9:1534-62. [PMID: 32526139 DOI: 10.1021/acssynbio.0c00210] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
19 Nguyen GT, Shaban L, Mack M, Swanson KD, Bunnell SC, Sykes DB, Mecsas J. SKAP2 is required for defense against K. pneumoniae infection and neutrophil respiratory burst. Elife 2020;9:e56656. [PMID: 32352382 DOI: 10.7554/eLife.56656] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Duke JA, Paschall AV, Robinson LS, Knoot CJ, Vinogradov E, Scott NE, Feldman MF, Avci FY, Harding CM. Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine. ACS Infect Dis 2021;7:3111-23. [PMID: 34633812 DOI: 10.1021/acsinfecdis.1c00415] [Reference Citation Analysis]
21 Nicolardi S, Danuser R, Dotz V, Domínguez-Vega E, Al Kaabi A, Beurret M, Anish C, Wuhrer M. Glycan and Protein Analysis of Glycoengineered Bacterial E. coli Vaccines by MALDI-in-Source Decay FT-ICR Mass Spectrometry. Anal Chem 2022. [PMID: 35293727 DOI: 10.1021/acs.analchem.1c04690] [Reference Citation Analysis]
22 Li Z, Ding Z, Tang M, Zeng Z, Song M, Yang K, Ding Y, Wang Z, Liu J. The molecular characteristics, clinical manifestations, 44 and risk factors of hypervirulent Klebsiella pneumoniae infections in a large teaching hospital in southwest China. Microb Pathog 2021;:105152. [PMID: 34742892 DOI: 10.1016/j.micpath.2021.105152] [Reference Citation Analysis]
23 Tu IF, Lin TL, Yang FL, Lee IM, Tu WL, Liao JH, Ko TP, Wu WJ, Jan JT, Ho MR, Chou CY, Wang AH, Wu CY, Wang JT, Huang KF, Wu SH. Structural and biological insights into Klebsiella pneumoniae surface polysaccharide degradation by a bacteriophage K1 lyase: implications for clinical use. J Biomed Sci 2022;29:9. [PMID: 35130876 DOI: 10.1186/s12929-022-00792-4] [Reference Citation Analysis]
24 Herrera CM, Voss BJ, Trent MS. Homeoviscous Adaptation of the Acinetobacter baumannii Outer Membrane: Alteration of Lipooligosaccharide Structure during Cold Stress. mBio 2021;12:e0129521. [PMID: 34425709 DOI: 10.1128/mBio.01295-21] [Reference Citation Analysis]
25 Lam MMC, Wick RR, Judd LM, Holt KE, Wyres KL. Kaptive 2.0: updated capsule and lipopolysaccharide locus typing for the Klebsiella pneumoniae species complex. Microb Genom 2022;8. [PMID: 35311639 DOI: 10.1099/mgen.0.000800] [Reference Citation Analysis]
26 Adegbite A, McCarthy PC. Recent and Future Advances in the Chemoenzymatic Synthesis of Homogeneous Glycans for Bacterial Glycoconjugate Vaccine Development. Vaccines (Basel) 2021;9:1021. [PMID: 34579258 DOI: 10.3390/vaccines9091021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Cai R, Deng H, Song J, Zhang L, Zhao R, Guo Z, Zhang X, Zhang H, Tian T, Ji Y, Shi K, Li J, Diao N, Han W, Gu J, Du R. Phage resistance mutation triggered by OmpC deficiency in Klebsiella pneumoniae induced limited fitness costs. Microb Pathog 2022;:105556. [PMID: 35489635 DOI: 10.1016/j.micpath.2022.105556] [Reference Citation Analysis]
28 Breiman RF, Blau DM, Mutevedzi P, Akelo V, Mandomando I, Ogbuanu IU, Sow SO, Madrid L, El Arifeen S, Garel M, Thwala NB, Onyango D, Sitoe A, Bassey IA, Keita AM, Alemu A, Alam M, Mahtab S, Gethi D, Varo R, Ojulong J, Samura S, Mehta A, Ibrahim AM, Rahman A, Vitorino P, Baillie VL, Agaya J, Tapia MD, Assefa N, Chowdhury AI, Scott JAG, Gurley ES, Kotloff KL, Jambai A, Bassat Q, Tippett-Barr BA, Madhi SA, Whitney CG; CHAMPS Consortium. Postmortem investigations and identification of multiple causes of child deaths: An analysis of findings from the Child Health and Mortality Prevention Surveillance (CHAMPS) network. PLoS Med 2021;18:e1003814. [PMID: 34591862 DOI: 10.1371/journal.pmed.1003814] [Reference Citation Analysis]
29 Wang LT, Wang HH, Chiang HC, Huang LY, Chiu SK, Siu LK, Liu KJ, Yen ML, Yen BL. Human Placental MSC-Secreted IL-1β Enhances Neutrophil Bactericidal Functions during Hypervirulent Klebsiella Infection. Cell Rep 2020;32:108188. [PMID: 32997996 DOI: 10.1016/j.celrep.2020.108188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
30 Banerjee K, Motley MP, Diago-Navarro E, Fries BC. Serum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients. mSphere 2021;6:e01335-20. [PMID: 33658281 DOI: 10.1128/mSphere.01335-20] [Reference Citation Analysis]
31 Brennan-Krohn T, Manetsch R, O'Doherty GA, Kirby JE. New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae. Transl Res 2020;220:14-32. [PMID: 32201344 DOI: 10.1016/j.trsl.2020.02.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
32 Artyszuk D, Izdebski R, Maciejewska A, Kaszowska M, Herud A, Szijártó V, Gniadkowski M, Lukasiewicz J. The Impact of Insertion Sequences on O-Serotype Phenotype and Its O-Locus-Based Prediction in Klebsiella pneumoniae O2 and O1. Int J Mol Sci 2020;21:E6572. [PMID: 32911792 DOI: 10.3390/ijms21186572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Anderluh M, Berti F, Bzducha-Wróbel A, Chiodo F, Colombo C, Compostella F, Durlik K, Ferhati X, Holmdahl R, Jovanovic D, Kaca W, Lay L, Marinovic-Cincovic M, Marradi M, Ozil M, Polito L, Reina JJ, Reis CA, Sackstein R, Silipo A, Švajger U, Vaněk O, Yamamoto F, Richichi B, van Vliet SJ. Recent advances on smart glycoconjugate vaccines in infections and cancer. FEBS J 2021. [PMID: 33934527 DOI: 10.1111/febs.15909] [Reference Citation Analysis]
34 Knoot CJ, Robinson LS, Harding CM. A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS. Glycobiology 2021:cwab043. [PMID: 33997889 DOI: 10.1093/glycob/cwab043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Fleeman RM, Macias LA, Brodbelt JS, Davies BW. Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae. Proc Natl Acad Sci U S A 2020;117:27620-6. [PMID: 33087568 DOI: 10.1073/pnas.2007036117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
36 Zhu H, Rollier CS, Pollard AJ. Recent advances in lipopolysaccharide-based glycoconjugate vaccines. Expert Rev Vaccines 2021;:1-24. [PMID: 34550840 DOI: 10.1080/14760584.2021.1984889] [Reference Citation Analysis]
37 Talat A, Khan AU. Vaccines against antimicrobial resistance: a promising escape route for multidrug resistance. Pharm Pat Anal 2021;10:83-98. [PMID: 33829866 DOI: 10.4155/ppa-2020-0022] [Reference Citation Analysis]
38 Tutelyan AV, Shlykova DS, Voskanyan SL, Gaponov AM, Pisarev VM. Molecular Epidemiology of Hypervirulent K. pneumoniae and Problems of Health-Care Associated Infections. Bull Exp Biol Med 2022. [PMID: 35352244 DOI: 10.1007/s10517-022-05424-3] [Reference Citation Analysis]
39 Malachowa N, Kobayashi SD, Porter AR, Freedman B, Hanley PW, Lovaglio J, Saturday GA, Gardner DJ, Scott DP, Griffin A, Cordova K, Long D, Rosenke R, Sturdevant DE, Bruno D, Martens C, Kreiswirth BN, DeLeo FR. Vaccine Protection against Multidrug-Resistant Klebsiella pneumoniae in a Nonhuman Primate Model of Severe Lower Respiratory Tract Infection. mBio 2019;10:e02994-19. [PMID: 31848292 DOI: 10.1128/mBio.02994-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
40 Li W, Hu Y, Zhang Q, Hua L, Yang Z, Ren Z, Zheng X, Huang W, Ma Y. Development of Drug-Resistant Klebsiella pneumoniae Vaccine via Novel Vesicle Production Technology. ACS Appl Mater Interfaces 2021;13:32703-15. [PMID: 34251169 DOI: 10.1021/acsami.1c06701] [Reference Citation Analysis]
41 Argimón S, David S, Underwood A, Abrudan M, Wheeler NE, Kekre M, Abudahab K, Yeats CA, Goater R, Taylor B, Harste H, Muddyman D, Feil EJ, Brisse S, Holt K, Donado-Godoy P, Ravikumar KL, Okeke IN, Carlos C, Aanensen DM; NIHR Global Health Research Unit on Genomic Surveillance of Antimicrobial Resistance . Rapid Genomic Characterization and Global Surveillance of Klebsiella Using Pathogenwatch. Clin Infect Dis 2021;73:S325-35. [PMID: 34850838 DOI: 10.1093/cid/ciab784] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Berti F, Micoli F. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs. Curr Opin Immunol 2020;65:42-9. [PMID: 32361591 DOI: 10.1016/j.coi.2020.03.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
43 Assoni L, Girardello R, Converso TR, Darrieux M. Current Stage in the Development of Klebsiella pneumoniae Vaccines. Infect Dis Ther 2021;10:2157-75. [PMID: 34476772 DOI: 10.1007/s40121-021-00533-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 López-Siles M, Corral-Lugo A, McConnell MJ. Vaccines for multidrug resistant Gram negative bacteria: lessons from the past for guiding future success. FEMS Microbiol Rev 2021;45:fuaa054. [PMID: 33289833 DOI: 10.1093/femsre/fuaa054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]